Reports
Sale
Europe Gene Expression Market Size, Share, Growth, Analysis: By Process: Sample Collection, Purification, cDNA Synthesis & Conversion, PCR Analysis, Data Analysis & Interpretation; By Application: Clinical Diagnostics, Others; By Technique; By Product; By End User; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Europe Gene Expression Market Outlook
The global gene expression market size was valued at USD 13.3 billion in 2023, with Europe holding a significant market share. It is driven by the increasing research activities and regulatory approvals. The market is expected to grow at a CAGR of 10.42% during the forecast period of 2024-2032, with the values likely to reach USD 32.4 billion by 2032.
Key Takeaways
- The market is projected to witness an upward trajectory owing to the increasing research and investment activities in new drug discoveries for chronic diseases such as cancer, among others.
- United Kingdom is cementing its position as the leading destination of clinical trials in cell and gene therapy in Europe and is expected to lead the Europe gene expression market share in coming years.
- The market is impacted by increasing approvals from regulatory authorities. In February 2024, Vertex Pharmaceuticals and CRISPR Therapeutics received European Commission’s marketing approval for Casgevy (exagamglogene autotemcel).
Europe Gene Expression Market Analysis
Gene expression enables any specific part of DNA to contribute to the basic functionality of different cells in the human body including nerve cells and neurons in the brain. It is a fundamental aspect of gene therapies as it includes procedures like altering or silencing genes within a patient's cells to treat or prevent disease.
In February 2024, Vertex Pharmaceuticals and CRISPR Therapeutics received regulatory approval for Casgevy (exagamglogene autotemcel) after receiving conditional marketing authorisation for gene therapy from the European Commission. The CRISPR treatment is the first gene therapy approved in Europe for sickle cell disease and transfusion-dependent beta-thalassemia (TDT). The approval of Casgevy for the treatment of sickle cell disease and transfusion-dependent beta-thalassemia (TDT) represents a significant development, propelling the Europe gene expression market growth.
United Kingdom’s market share is poised to witness a notable upswing in the forecast period. The growth can be attributed to its increasing expenditure on conducting more clinical trials in cell and gene therapy. United Kingdom is the leading destination for cell and gene therapy clinical trials, with 84 drugs in clinical development as of October 2023, followed by France (45), Spain (44), and Germany (40). Europe gene expression market demand is further fuelled by abundance of innovations in bioscience and healthcare. Despite experiencing significant lows in the past, market players have significantly gained hefty investments as venture capital (VC) funding. Notably, half of the VC funding has been secured by European cell and gene therapy companies in 2023 contributing to the expansion of market share.
With increasing preference for personalised medicine, gene expression is finding its application in treatment of several chronic diseases, including cancer. This is one of the major Europe gene expression market trends. In January 2024, researchers from the Wellcome Sanger Institute conducted an analysis of 370 candidate priority drugs across various cancer types including lung, ovarian and breast candidates. With gene expression analysis, the comprehension of the functional and genomic information of cancer cells becomes feasible contributing to the development of more effective cancer treatments. Such advancements in cancer research and therapy development with gene expression are likely to significantly impact the gene expression market in Europe and globally.
Europe Gene Expression Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Process | Sample Collection, Purification, cDNA Synthesis and Conversion, PCR Analysis, Data Analysis and Interpretation |
| Application | Clinical Diagnostics, Drug Discovery and Development, Research Activities, other applications |
| Technique | RNA Expression, Promoter Analysis, Protein Expression, and Posttranslational Modification Analysis |
| Product | Consumables, Instruments, Services |
| End User | Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, Academic Research Centers |
| Country | United Kingdom, Germany, France, Italy |
Europe Gene Expression Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- F. Hoffmann-La Roche Ltd
- QIAGEN
- Oxford Gene Technology (OGT) Group
- Eurofins Scientific
- LGC Limited
- Promega Corporation
- Takara Bio Inc.
- PacBio
- Smith & Nephew plc
- Abbott
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Process |
|
| Breakup by Application |
|
| Breakup by Technique |
|
| Breakup by Product |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Europe Gene Expression Market Overview
3.1 Europe Gene Expression Market Historical Value (2017-2023)
3.2 Europe Gene Expression Market Forecast Value (2024-2032)
4 Europe Gene Expression Market Landscape*
4.1 Europe Gene Expression: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Europe Gene Expression: Product Landscape
4.2.1 Analysis by Process
4.2.2 Analysis by Application
5 Europe Gene Expression Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Europe Gene Expression Market Segmentation (2017-2032)
6.1 Europe Gene Expression Market (2017-2032) by Process
6.1.1 Market Overview
6.1.2 Sample Collection
6.1.3 Purification
6.1.4 cDNA Synthesis & Conversion
6.1.5 PCR Analysis
6.1.6 Data Analysis & Interpretation
6.2 Europe Gene Expression Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Clinical Diagnostics
6.2.3 Drug Discovery & Development
6.2.4 Research Activities
6.2.5 Other Applications
6.3 Europe Gene Expression Market (2017-2032) by Technique
6.3.1 Market Overview
6.3.2 RNA Expression
6.3.3 Promoter Analysis
6.3.4 Protein Expression & Posttranslational Modification Analysis
6.4 Europe Gene Expression Market (2017-2032) by Product
6.4.1 Market Overview
6.4.2 Consumables
6.4.3 Instruments
6.4.4 Services
6.5 Europe Gene Expression Market (2017-2032) by End User
6.5.1 Market Overview
6.5.2 Pharmaceutical and biotechnology companies
6.5.3 Diagnostic laboratories
6.5.4 Academic research centers
6.6 Europe Gene Expression Market (2017-2032) by Country
6.6.1 Market Overview
6.6.2 United Kingdom
6.6.3 Germany
6.6.4 France
6.6.5 Italy
7 United Kingdom Gene Expression Market (2017-2032)
7.1 United Kingdom Gene Expression Market (2017-2032) by Process
7.1.1 Market Overview
7.1.2 Sample Collection
7.1.3 Purification
7.1.4 cDNA synthesis & conversion
7.1.5 PCR Analysis
7.1.6 Data analysis & interpretation
7.2 United Kingdom Gene Expression Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Clinical Diagnostics
7.2.3 Drug Discovery & Development
7.2.4 Research Activities
7.2.5 Other Applications
7.3 United Kingdom Gene Expression Market (2017-2032) by Technique
7.3.1 Market Overview
7.3.2 RNA Expression
7.3.3 Promoter Analysis
7.3.4 Protein Expression & Posttranslational Modification Analysis
7.4 United Kingdom Gene Expression Market (2017-2032) by Product
7.4.1 Market Overview
7.4.2 Consumables
7.4.3 Instruments
7.4.4 Services
7.5 United Kingdom Gene Expression Market (2017-2032) by End User
7.5.1 Market Overview
7.5.2 Pharmaceutical and biotechnology companies
7.5.3 Diagnostic laboratories
7.5.4 Academic research centers
8 Germany Gene Expression Market (2017-2032)
8.1 Germany Gene Expression Market (2017-2032) by Process
8.1.1 Market Overview
8.1.2 Sample Collection
8.1.3 Purification
8.1.4 cDNA synthesis & conversion
8.1.5 PCR Analysis
8.1.6 Data analysis & interpretation
8.2 Germany Gene Expression Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Clinical Diagnostics
8.2.3 Drug Discovery & Development
8.2.4 Research Activities
8.2.5 Other Applications
8.3 Germany Gene Expression Market (2017-2032) by Technique
8.3.1 Market Overview
8.3.2 RNA Expression
8.3.3 Promoter Analysis
8.3.4 Protein Expression & Posttranslational Modification Analysis
8.4 Germany Gene Expression Market (2017-2032) by Product
8.4.1 Market Overview
8.4.2 Consumables
8.4.3 Instruments
8.4.4 Services
8.5 Germany Gene Expression Market (2017-2032) by End User
8.5.1 Market Overview
8.5.2 Pharmaceutical and biotechnology companies
8.5.3 Diagnostic laboratories
8.5.4 Academic research centers
9 France Gene Expression Market (2017-2032)
9.1 France Gene Expression Market (2017-2032) by Process
9.1.1 Market Overview
9.1.2 Sample Collection
9.1.3 Purification
9.1.4 cDNA synthesis & conversion
9.1.5 PCR Analysis
9.1.6 Data analysis & interpretation
9.2 France Gene Expression Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Clinical Diagnostics
9.2.3 Drug Discovery & Development
9.2.4 Research Activities
9.2.5 Other Applications
9.3 France Gene Expression Market (2017-2032) by Technique
9.3.1 Market Overview
9.3.2 RNA Expression
9.3.3 Promoter Analysis
9.3.4 Protein Expression & Posttranslational Modification Analysis
9.4 France Gene Expression Market (2017-2032) by Product
9.4.1 Market Overview
9.4.2 Consumables
9.4.3 Instruments
9.4.4 Services
9.5 France Gene Expression Market (2017-2032) by End User
9.5.1 Market Overview
9.5.2 Pharmaceutical and biotechnology companies
9.5.3 Diagnostic laboratories
9.5.4 Academic research centers
10 Italy Gene Expression Market (2017-2032)
10.1 Italy Gene Expression Market (2017-2032) by Process
10.1.1 Market Overview
10.1.2 Sample Collection
10.1.3 Purification
10.1.4 cDNA synthesis & conversion
10.1.5 PCR Analysis
10.1.6 Data analysis & interpretation
10.2 Italy Gene Expression Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Clinical Diagnostics
10.2.3 Drug Discovery & Development
10.2.4 Research Activities
10.2.5 Other Applications
10.3 Italy Gene Expression Market (2017-2032) by Technique
10.3.1 Market Overview
10.3.2 RNA Expression
10.3.3 Promoter Analysis
10.3.4 Protein Expression & Posttranslational Modification Analysis
10.4 Italy Gene Expression Market (2017-2032) by Product
10.4.1 Market Overview
10.4.2 Consumables
10.4.3 Instruments
10.4.4 Services
10.5 Italy Gene Expression Market (2017-2032) by End User
10.5.1 Market Overview
10.5.2 Pharmaceutical and biotechnology companies
10.5.3 Diagnostic laboratories
10.5.4 Academic research centers
11 Regulatory Framework
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication Year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by Year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by Departments
13.7 Analysis by Recipient Organization
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 Market Share by Top 5 Companies
16.2 F. Hoffmann-La Roche Ltd
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 QIAGEN
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Oxford Gene Technology (OGT) Group
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Eurofins Scientific
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 LGC Limited
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Promega Corporation
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Takara Bio Inc.
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 PacBio
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 Smith & Nephew plc.
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 Abbott
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
17 Europe Gene Expression Market – Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market is anticipated to be driven by the growing demand in the global market, which is estimated to grow at a CAGR of 10.42% during the forecast period of 2024-2032, likely to reach a market value of USD 32.4 billion by 2032.
Factors influencing the market are the rising number of regulatory clearances representing significant advancements in technologies.
One of the significant trends in the market is the increasing investment activities by the key players in the market.
The segmentations include sample collection, purification, cDNA synthesis and conversion, PCR analysis, and data analysis and interpretation.
Common application areas include clinical diagnostics, drug discovery and development, research activities, among others.
Techniques include RNA expression, promoter analysis, protein expression, and posttranslational modification analysis.
Products include consumables, instruments, and services.
The end users include pharmaceutical and biotechnology companies, diagnostic laboratories, and academic research centers.
The market segmentation by countries includes the United Kingdom, Germany, France, and Italy.
The key players in the market are F. Hoffmann-La Roche Ltd, QIAGEN, Oxford Gene Technology (OGT) Group, Eurofins Scientific, LGC Limited, Promega Corporation, Takara Bio Inc., PacBio, Smith & Nephew plc, and Abbott.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER